Recent discoveries by this PPG research team in clinical lung transplantation, idiopathic pulmonary flbrosis and cardiac atherosclerosis suggest that THI 7 T cells specific for epitopes of the minor collagen type V [col(V)] may be a common feature of fibro-obliterative diseases of airways and vasculature. Neariy 80% of lung transplants and 50% of heart transplants will succumb to chronic fibro-obliterative disease [BOS and CAV] over a 10 year period. The goal of this project is to test the hypothesis that collagen V plays a central role in chronic rejection of both heart and lung transplants. We will identify its immunodominant T cell epitopes , analyze the mechanisms of immunopathology mediated by col(V)-specific IL17-producing T cells, and determine if suppression by donor HLA-specific or col(V)-specific Treg cells can halt the progression of an airway or vascular occlusive lesion. We propose 4 specific aims: first, we will identify which col (V) peptides drive the CD4 T cell response of col(V)-sensitized individuals in 3 different class II contexts: human HLA-DR1, and 17, and mouse IA. We will then use these peptides to create class ll-peptide tetramers that react specifically with cognate pMHC-specific CD4 T cells (Aim 1). T cell cloning, both conventional &tetramer-assisted, will be used to identify, and characterize antigen- specific CD4 T cells and to study their interaction with APC and fibrillar collagen. We will compare col (V)-specific THI7 and TT-specific THI cellular immune responses in mice and humans (Aim 2).
In Aim 3, MHC-I &MHC ll/peptide tetramers, DTH, ELISPOT, intracellular cytokine and multiplex cytokine arrays will be used to trace the emergence of allo-specific and col(V)-specific T cells in mouse heart allograft models of chronic allograft vasculopathy [CAV], using atherosclerosis-prone, APO-e deficient and wt B6 mice as recipients. We will also explore the natural history of a pathogenic col(V)-specific T cell response using epitope-specific probes in non-transplanted, high-fat diet-fed APO-e mice. To determine if overexpression ofthe ?1(V) chain is the driving force in TH17 -mediated flbro-obliterative disease, will also test ?2(V)-deflcient and epitope-modified ?1(V) Tg mice [generated in project 1] as heart transplant donors and recipients (Aim 3). Finally, we will investigate the role of Treg cells in blocking or reversing allo-to-auto/col(V) epitope spreading in a study of human heart and lung transplant recipients (Aim 4), and by tolerizing mice to col(V) prior to heart allografting (Aim 3). Our T cell studies will be bolstered by the serum col V -speciflc IgG analysis in project 3, and will make extensive use of transgenic and immunopatholgy cores.

Public Health Relevance

The Studies proposed will advance our understanding of the T cells that cause blockage of vessels and airways in chronic rejection of organ transplants. The knowledge gained will be used to design strategies to prevent graft loss and promote transplant acceptance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI084853-05
Application #
8713906
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
5
Fiscal Year
2014
Total Cost
Indirect Cost
City
Indianapolis
State
IN
Country
United States
Zip Code
Muir, Alison M; Massoudi, Dawiyat; Nguyen, Ngon et al. (2016) BMP1-like proteinases are essential to the structure and wound healing of skin. Matrix Biol 56:114-131
Park, Arick C; Huang, Guorui; Jankowska-Gan, Ewa et al. (2016) Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance. J Biol Chem 291:3359-70
Park, Arick C; Phillips, Charlotte L; Pfeiffer, Ferris M et al. (2015) Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype. Am J Pathol 185:2000-11
Wu, Q; Gupta, P K; Suzuki, H et al. (2015) CD4 T Cells but Not Th17 Cells Are Required for Mouse Lung Transplant Obliterative Bronchiolitis. Am J Transplant 15:1793-804
Shah, Rupal J; Emtiazjoo, Amir M; Diamond, Joshua M et al. (2014) Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med 189:1564-7
Gracon, Adam S A; Wilkes, David S (2014) Lung transplantation: chronic allograft dysfunction and establishing immune tolerance. Hum Immunol 75:887-94
Weber, Daniel J; Gracon, Adam S A; Ripsch, Matthew S et al. (2014) The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation. Sci Transl Med 6:252ra124
Sullivan, Jeremy A; Adams, Andrew B; Burlingham, William J (2014) The emerging role of TH17 cells in organ transplantation. Transplantation 97:483-9
Pandya, Pankita H; Wilkes, David S (2014) Complement system in lung disease. Am J Respir Cell Mol Biol 51:467-73
Sullivan, J A; Jankowska-Gan, E; Shi, L et al. (2014) Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses. Am J Transplant 14:1512-22

Showing the most recent 10 out of 29 publications